|
(11) | EP 1 744 734 A2 |
| (12) |
|
|
|
|
|||||||||||||||
| (54) | THERAPEUTIC COMBINATION COMPRISING A TISSUE FACTOR ANTAGONIST AND ANTI-CANCER COMPOUNDS |